EP4135756
C1 esterasa hindri til að meðhöndla andnauð sem tengist sýkingu af kórónuveiru
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.4.2021EP published:
27.3.2024EP application number:
21718158.5
EP translation filed:
27.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
18.4.2041Expiry date:
18.4.2026Next due date:
30.4.2026
Title in English:
C1 ESTERASE INHIBITOR TO TREAT CORONAVIRAL INFECTION-RELATED RESPIRATORY DISTRESSLanguage of the patent:
English
Timeline
Today
19.4.2021EP application
27.3.2024EP Publication
27.5.2024Translation submitted
15.6.2024Registration published
18.4.2026Expires
Owner
Name:
Pharming Intellectual Property B.V.Address:
Darwinweg 24, 2333 CR Leiden, NL
Inventor
Name:
GIANNETTI, BrunoAddress:
2333 CR Leiden, NL
Name:
RELAN, AnuragAddress:
2333 CR Leiden, NL
Name:
SCHAALE-MAASS, Juergen UlrichAddress:
2333 CR Leiden, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
20170253Date:
17.4.2020Country:
EP
Number:
202063011738 PDate:
17.4.2020Country:
US
Classification
Categories:
A61K 38/57, C07K 14/81, A61P 11/00, A61P 31/12, A61P 31/14, A61P 31/16, C07K 14/44
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 29.4.2024
Expires: 18.4.2025
Payer: Árnason Faktor ehf.
Number: 5
Paid: 28.4.2025
Expires: 18.4.2026
Payer: Árnason Faktor ehf.